Qrons: Qrons Inc.: Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
NEW YORK, NY / ACCESSWIRE / August 14, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products to combat neuronal and infectious diseases with a focus on...
Read full article »
Qrons engages in developing solutions for traumatic brain injury, Parkinson's, Huntington's and Alzheimer's diseases.
Read more